Search Results - "Mao, Qingfeng"

A review of radiation-induced lymphopenia in patients with esophageal cancer: an immunological perspective for radiotherapy by Wang, Xin, Wang, Peiliang, Zhao, Zongxing, Mao, Qingfeng, Yu, Jinming, Li, Minghuan

“…Radiotherapy is a frequently utilized therapeutic modality in the treatment of esophageal cancer (EC). Even though extensive studies are carried out in…”
Get full text

A dosimetric and radiobiological evaluation of VMAT following mastectomy for patients with left-sided breast cancer by Zhang, Yun, Huang, Yuling, Ding, Shenggou, Yuan, Xingxing, Shu, Yuxian, Liang, Jinhui, Mao, Qingfeng, Jiang, Chunling, Li, Jingao

“…To compare the dosimetric, normal tissue complication probability (NTCP), secondary cancer complication probabilities (SCCP), and excess absolute risk (EAR)…”
Get full text

The flow-metabolism ratio might predict treatment response and survival in patients with locally advanced esophageal squamous cell carcinoma by Zhao, Kewei, Wang, Chunsheng, Mao, Qingfeng, Shang, Dongping, Huang, Yong, Ma, Li, Yu, Jinming, Li, Minghuan

“…Background Perfusion CT can offer functional information about tumor angiogenesis, and 18 F-FDG PET/CT quantifies the glucose metabolic activity of tumors…”
Get full text

A clinical trial to compare a 3D‐printed bolus with a conventional bolus with the aim of reducing cardiopulmonary exposure in postmastectomy patients with volumetric modulated arc therapy by Zhang, Yun, Huang, Yuling, Ding, Shenggou, Liang, Jinghui, Kuang, Jie, Mao, Qingfeng, Ying, Weiliang, Shu, Yuxian, Li, Jingao, Jiang, Chunling

“…Background We compared the dosimetry, application, and acute toxicity of a 3D‐printed and a conventional bolus for postmastectomy radiotherapy (PMRT) with…”
Get full text

Radiotherapy for esophageal carcinoma: dose, response and survival by Luo, Yijun, Mao, Qingfeng, Wang, Xiaoli, Yu, Jinming, Li, Minghuan

“…Esophageal cancer (EC) is an extremely aggressive, lethal malignancy that is increasing in incidence worldwide. At present, definitive chemoradiotherapy is…”
Get full text

Expressing MLH1 in HCT116 cells increases cellular resistance to radiation by activating the PRKAC by Huang, Yuling, Feng, Liu, Bao, Yongqiang, Zhang, Yun, Liang, Jinghui, Mao, Qingfeng, Li, Jingao, Jiang, Chunling

“…Mut L homolog-1 (MLH1) is a key DNA mismatch repair protein which participates in the sensitivity to DNA damaging agents. However, its role in the…”
Get full text

Cover Image by Zhang, Yun, Huang, Yuling, Ding, Shenggou, Liang, Jinghui, Kuang, Jie, Mao, Qingfeng, Ying, Weiliang, Shu, Yuxian, Li, Jingao, Jiang, Chunling

Get full text